Acadia Pharma (ACAD) Misses Q4 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Acadia Pharma (ACAD) Misses Q4 EPS by 1c

Acadia Pharmaceuticals (ACAD) PT Lowered to $39 at Mizuho, 'Daybue Seasonality Trend May Raise Concerns'

February 28, 2024 6:15 AM EST

Mizuho Securities analyst Uy Ear lowered the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $39.00 (from $40.00) while maintaining a Buy rating.

The analyst comments "With investor focus on the Daybue launch, ACAD will likely trade down today. We would buy on weakness. Investors... More